GE Healthcare has announced the availability of new diagnostic scan for Parkinson's disease called the DaTscan (Ioflupane I 123 Injection).
"The DaTscan is of great interest to us. If this scan can be used in the pre-symptomatic phase of PD, that is before PD'ers are are aware that they have the disease, we may be able to target PD at a time-point with the greatest potential to modify the course of the disease."
"The DaTscan is of great interest to us. If this scan can be used in the pre-symptomatic phase of PD, that is before PD'ers are are aware that they have the disease, we may be able to target PD at a time-point with the greatest potential to modify the course of the disease."
For more information see the Diagnostic Imaging press release.
Conflict of interest: I have consulted for GE-Heathcare in the past in relation to multiple sclerosis.
No comments:
Post a Comment